Free Trial
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free OACC Stock Alerts

Oaktree Acquisition Corp. III Life Sciences (OACC) Competitors

Oaktree Acquisition Corp. III Life Sciences logo
$10.68 +0.04 (+0.38%)
Closing price 05/15/2026 02:41 PM Eastern
Extended Trading
$10.64 -0.04 (-0.33%)
As of 05/15/2026 04:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

OACC vs. ESRT, RPC, JBGS, ABX, and IPXX

Should you buy Oaktree Acquisition Corp. III Life Sciences stock or one of its competitors? MarketBeat compares Oaktree Acquisition Corp. III Life Sciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Oaktree Acquisition Corp. III Life Sciences include Empire State Realty Trust (ESRT), Ridgepost Capital (RPC), JBG SMITH Properties (JBGS), Abacus Global Management (ABX), and Inflection Point Acquisition Corp. II (IPXX). These companies are all part of the "trading" industry.

How does Oaktree Acquisition Corp. III Life Sciences compare to Empire State Realty Trust?

Empire State Realty Trust (NYSE:ESRT) and Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) are both small-cap trading companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, media sentiment, institutional ownership, analyst recommendations and profitability.

67.1% of Empire State Realty Trust shares are held by institutional investors. 15.2% of Empire State Realty Trust shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Empire State Realty Trust has higher revenue and earnings than Oaktree Acquisition Corp. III Life Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Empire State Realty Trust$776.71M1.20$47.60M$0.2620.71
Oaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/A

Empire State Realty Trust has a net margin of 5.09% compared to Oaktree Acquisition Corp. III Life Sciences' net margin of 0.00%. Empire State Realty Trust's return on equity of 2.19% beat Oaktree Acquisition Corp. III Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Empire State Realty Trust5.09% 2.19% 0.93%
Oaktree Acquisition Corp. III Life Sciences N/A N/A N/A

In the previous week, Empire State Realty Trust had 1 more articles in the media than Oaktree Acquisition Corp. III Life Sciences. MarketBeat recorded 2 mentions for Empire State Realty Trust and 1 mentions for Oaktree Acquisition Corp. III Life Sciences. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 1.87 beat Empire State Realty Trust's score of 0.57 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
Empire State Realty Trust Positive
Oaktree Acquisition Corp. III Life Sciences Very Positive

Empire State Realty Trust presently has a consensus price target of $6.35, suggesting a potential upside of 17.92%. Given Empire State Realty Trust's stronger consensus rating and higher possible upside, research analysts plainly believe Empire State Realty Trust is more favorable than Oaktree Acquisition Corp. III Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Empire State Realty Trust
2 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.33
Oaktree Acquisition Corp. III Life Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Empire State Realty Trust has a beta of 1.35, meaning that its stock price is 35% more volatile than the broader market. Comparatively, Oaktree Acquisition Corp. III Life Sciences has a beta of -0.02, meaning that its stock price is 102% less volatile than the broader market.

Summary

Empire State Realty Trust beats Oaktree Acquisition Corp. III Life Sciences on 10 of the 11 factors compared between the two stocks.

How does Oaktree Acquisition Corp. III Life Sciences compare to Ridgepost Capital?

Ridgepost Capital (NYSE:RPC) and Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) are both small-cap financial services companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, media sentiment, institutional ownership, analyst recommendations and profitability.

48.1% of Ridgepost Capital shares are held by institutional investors. 11.5% of Ridgepost Capital shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Ridgepost Capital has higher revenue and earnings than Oaktree Acquisition Corp. III Life Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ridgepost Capital$297.35M3.05$19.50M$0.2237.65
Oaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/A

Ridgepost Capital has a net margin of 7.99% compared to Oaktree Acquisition Corp. III Life Sciences' net margin of 0.00%. Ridgepost Capital's return on equity of 24.58% beat Oaktree Acquisition Corp. III Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Ridgepost Capital7.99% 24.58% 10.56%
Oaktree Acquisition Corp. III Life Sciences N/A N/A N/A

In the previous week, Ridgepost Capital had 2 more articles in the media than Oaktree Acquisition Corp. III Life Sciences. MarketBeat recorded 3 mentions for Ridgepost Capital and 1 mentions for Oaktree Acquisition Corp. III Life Sciences. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 1.87 beat Ridgepost Capital's score of 0.00 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
Ridgepost Capital Neutral
Oaktree Acquisition Corp. III Life Sciences Very Positive

Ridgepost Capital presently has a consensus price target of $12.00, suggesting a potential upside of 44.86%. Given Ridgepost Capital's stronger consensus rating and higher possible upside, research analysts plainly believe Ridgepost Capital is more favorable than Oaktree Acquisition Corp. III Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ridgepost Capital
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
Oaktree Acquisition Corp. III Life Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Ridgepost Capital has a beta of 0.88, meaning that its stock price is 12% less volatile than the broader market. Comparatively, Oaktree Acquisition Corp. III Life Sciences has a beta of -0.02, meaning that its stock price is 102% less volatile than the broader market.

Summary

Ridgepost Capital beats Oaktree Acquisition Corp. III Life Sciences on 11 of the 12 factors compared between the two stocks.

How does Oaktree Acquisition Corp. III Life Sciences compare to JBG SMITH Properties?

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) and JBG SMITH Properties (NYSE:JBGS) are both small-cap trading companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings, media sentiment and analyst recommendations.

In the previous week, JBG SMITH Properties had 1 more articles in the media than Oaktree Acquisition Corp. III Life Sciences. MarketBeat recorded 2 mentions for JBG SMITH Properties and 1 mentions for Oaktree Acquisition Corp. III Life Sciences. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 1.87 beat JBG SMITH Properties' score of 0.78 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
Oaktree Acquisition Corp. III Life Sciences Very Positive
JBG SMITH Properties Positive

Oaktree Acquisition Corp. III Life Sciences has a net margin of 0.00% compared to JBG SMITH Properties' net margin of -22.16%. Oaktree Acquisition Corp. III Life Sciences' return on equity of 0.00% beat JBG SMITH Properties' return on equity.

Company Net Margins Return on Equity Return on Assets
Oaktree Acquisition Corp. III Life SciencesN/A N/A N/A
JBG SMITH Properties -22.16%-9.32%-2.53%

98.5% of JBG SMITH Properties shares are owned by institutional investors. 11.9% of JBG SMITH Properties shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

JBG SMITH Properties has a consensus price target of $18.50, indicating a potential upside of 30.13%. Given JBG SMITH Properties' higher probable upside, analysts plainly believe JBG SMITH Properties is more favorable than Oaktree Acquisition Corp. III Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oaktree Acquisition Corp. III Life Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
JBG SMITH Properties
2 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Oaktree Acquisition Corp. III Life Sciences has higher earnings, but lower revenue than JBG SMITH Properties.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/A
JBG SMITH Properties$498.60M1.66-$139.06M-$1.87N/A

Oaktree Acquisition Corp. III Life Sciences has a beta of -0.02, meaning that its stock price is 102% less volatile than the broader market. Comparatively, JBG SMITH Properties has a beta of 1.09, meaning that its stock price is 9% more volatile than the broader market.

Summary

JBG SMITH Properties beats Oaktree Acquisition Corp. III Life Sciences on 6 of the 10 factors compared between the two stocks.

How does Oaktree Acquisition Corp. III Life Sciences compare to Abacus Global Management?

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) and Abacus Global Management (NYSE:ABX) are both small-cap financial services companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings, media sentiment and analyst recommendations.

In the previous week, Abacus Global Management had 7 more articles in the media than Oaktree Acquisition Corp. III Life Sciences. MarketBeat recorded 8 mentions for Abacus Global Management and 1 mentions for Oaktree Acquisition Corp. III Life Sciences. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 1.87 beat Abacus Global Management's score of 0.46 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
Oaktree Acquisition Corp. III Life Sciences Very Positive
Abacus Global Management Neutral

Abacus Global Management has a net margin of 15.63% compared to Oaktree Acquisition Corp. III Life Sciences' net margin of 0.00%. Abacus Global Management's return on equity of 20.02% beat Oaktree Acquisition Corp. III Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Oaktree Acquisition Corp. III Life SciencesN/A N/A N/A
Abacus Global Management 15.63%20.02%9.65%

Abacus Global Management has a consensus price target of $10.00, indicating a potential upside of 9.83%. Given Abacus Global Management's stronger consensus rating and higher probable upside, analysts plainly believe Abacus Global Management is more favorable than Oaktree Acquisition Corp. III Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oaktree Acquisition Corp. III Life Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Abacus Global Management
0 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Abacus Global Management has higher revenue and earnings than Oaktree Acquisition Corp. III Life Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/A
Abacus Global Management$235.24M3.74$36.53M$0.3923.35

Oaktree Acquisition Corp. III Life Sciences has a beta of -0.02, meaning that its stock price is 102% less volatile than the broader market. Comparatively, Abacus Global Management has a beta of 0.11, meaning that its stock price is 89% less volatile than the broader market.

Summary

Abacus Global Management beats Oaktree Acquisition Corp. III Life Sciences on 8 of the 9 factors compared between the two stocks.

How does Oaktree Acquisition Corp. III Life Sciences compare to Inflection Point Acquisition Corp. II?

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) and Inflection Point Acquisition Corp. II (NASDAQ:IPXX) are both small-cap financial services companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, profitability, institutional ownership, media sentiment, earnings and analyst recommendations.

In the previous week, Oaktree Acquisition Corp. III Life Sciences had 1 more articles in the media than Inflection Point Acquisition Corp. II. MarketBeat recorded 1 mentions for Oaktree Acquisition Corp. III Life Sciences and 0 mentions for Inflection Point Acquisition Corp. II. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 1.87 beat Inflection Point Acquisition Corp. II's score of 0.00 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
Oaktree Acquisition Corp. III Life Sciences Very Positive
Inflection Point Acquisition Corp. II Neutral

Company Net Margins Return on Equity Return on Assets
Oaktree Acquisition Corp. III Life SciencesN/A N/A N/A
Inflection Point Acquisition Corp. II N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/A
Inflection Point Acquisition Corp. IIN/AN/AN/AN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oaktree Acquisition Corp. III Life Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Inflection Point Acquisition Corp. II
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Oaktree Acquisition Corp. III Life Sciences has a beta of -0.02, suggesting that its stock price is 102% less volatile than the broader market. Comparatively, Inflection Point Acquisition Corp. II has a beta of 0.17, suggesting that its stock price is 83% less volatile than the broader market.

Summary

Oaktree Acquisition Corp. III Life Sciences beats Inflection Point Acquisition Corp. II on 3 of the 4 factors compared between the two stocks.

Get Oaktree Acquisition Corp. III Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for OACC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OACC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OACC vs. The Competition

Export
MetricOaktree Acquisition Corp. III Life SciencesInvestment Offices IndustryFinancial SectorNASDAQ Exchange
Market Cap$261.56M$315.36M$5.16B$12.30B
Dividend YieldN/AN/A5.25%5.27%
P/E RatioN/A1.1815.9225.27
Price / SalesN/A226.23996.1075.59
Price / CashN/A134.2190.2554.86
Price / BookN/A347.496.596.90
Net IncomeN/A-$66.73M$1.15B$334.66M
7 Day Performance-0.56%0.87%-0.26%0.12%
1 Month Performance0.04%2.43%0.64%-0.18%
1 Year Performance2.20%6.54%18.08%30.62%

Oaktree Acquisition Corp. III Life Sciences Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OACC
Oaktree Acquisition Corp. III Life Sciences
N/A$10.68
+0.4%		N/A+2.2%$261.56MN/AN/AN/A
ESRT
Empire State Realty Trust
2.6192 of 5 stars		$5.72
+1.9%		$6.35
+11.1%		-31.0%$977.78M$768.27M21.98670
RPC
Ridgepost Capital
4.4689 of 5 stars		$8.76
+3.6%		$12.00
+37.0%		N/A$958.17M$297.35M39.83180
JBGS
JBG SMITH Properties
1.575 of 5 stars		$15.55
+0.9%		$18.50
+19.0%		-14.2%$906.46M$498.60MN/A910
ABX
Abacus Global Management
2.0936 of 5 stars		$9.04
-3.7%		$10.00
+10.7%		N/A$876.60M$235.24M23.1782

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:OACC) was last updated on 5/17/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
SpaceX Goes Public. Here's What Happens To Your IRA.
When SpaceX goes public, fund managers will sell existing portfolio holdings to fund the move. Trillions in as...
Americas Gold Company | Sponsoredtc pixel